The AT-II/AT1R axis activates PKC, which mediates the activation of several downstream effectors, including extracellular-signal-regulated kinase 1/2, p38, and c-Jun N-terminal kinase, resulting in fibrogenic gene transcription in HSC-driven liver fibrosis [38,39]. The gene discussed is MAPK3; the disease is Hepatic fibrosis.